Targeted Oncology: Highlighting current advances for the treatment of myeloproliferative neoplasms
January 28, 2020
Ruben Mesa discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms (MPNs).
AJMC: Dr. Ruben Mesa outlines the quality of life impact of myelofibrosis
January 27, 2020
Ruben Mesa, MD, director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the impact myelofibrosis has on patients’ quality of life while at the American Society of Hematology conference.
KSAT 12: Infectious disease specialist says there’s no need to panic about new strain of coronavirus
January 23, 2020
Dr. Jason Bowling, an associate professor of infectious diseases at UT Health San Antonio, tells KSAT’s Jessie Degollado that the U.S. has “no need to panic right now” amid international efforts to contain the coronavirus, a respiratory disease, that began in China. There is one coronavirus patient in the U.S. who is recovering in Seattle. […]
Targeted Oncology: Expert highlights benefits of Fedratinib in subgroup of patients with myelofibrosis
January 22, 2020
Dr. Ruben Mesa, director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discussed the benefits of Fedratinib (Inrebic) for the treatment of adult patients with intermediate-2 or high-risk primary or secondary myelofibrosis. Read the full story
Texas Public Radio: Rubella poses grave threat for pregnant women
January 21, 2020
Dr. Jason Bowling, an associate professor of infectious diseases at UT Health San Antonio, was interviewed about the threat of the rubella virus, especially for unvaccinated pregnant women.
Texas Public Radio: This flu season is hitting children hardest
January 16, 2020
Dr. Jason Bowling, an associate professor of infectious diseases at UT Health San Antonio, explains that the predominant strain of influenza circulating right now is Influenza B.